Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Diagnosed With Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06799676
What this trial is testing

A Phase Ib/II Clinical Study on the Application of Linperlisib Combined with the VRD Regimen in Newly Diagnosed Patients with Multiple Myeloma

Who this might be right for
Newly Diagnosed Multiple Myeloma
Fuling Zhou 42
Not applicableEnrolling By InvitationNCT07363980
What this trial is testing

Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study

Who this might be right for
Rheumatoid ArthritisAtherosclerotic Ischemic DiseasePulmonary Disease+14 more
Ellen Margrethe Hauge 4,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT06048718
What this trial is testing

T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases

Who this might be right for
Breast CancerMetastatic Breast Cancer
MedSIR 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06367374
What this trial is testing

MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07698613
What this trial is testing

EGFR Targeted Photoimmunotherapy With ASP-1929 for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical ResectionPancreatic Cancer BorderlinePancreatic Cancer Resectable
Brown University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04019262
What this trial is testing

Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
John Flickinger 2
Not applicableStudy completedNCT01085617
What this trial is testing

Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
LeukemiaMucositisOral Complications
University College, London
Testing effectiveness (Phase 2)Study completedNCT00980395
What this trial is testing

Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma

Who this might be right for
LymphomaMantle Cell LymphomaIndolent Lymphoma+1 more
University of Arizona 24
Large-scale testing (Phase 3)Study completedNCT00085098
What this trial is testing

Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor

Who this might be right for
Brain TumorCentral Nervous System Tumor
Children's Oncology Group 24
Early research (Phase 1)Active Not RecruitingNCT05743595
What this trial is testing

Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Who this might be right for
Unmethylated Glioblastoma
Washington University School of Medicine 27
Testing effectiveness (Phase 2)Study completedNCT00003671
What this trial is testing

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 59
Large-scale testing (Phase 3)Looking for participantsNCT06750419
What this trial is testing

89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study

Who this might be right for
Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 82
Not applicableStudy completedNCT07057895
What this trial is testing

Diagnostic Consistency of GLIM and PG-SGA for Malnutrition in Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
The First Hospital of Hebei Medical University 108
Not applicableStudy completedNCT01501630
What this trial is testing

Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer

Who this might be right for
Prostate Cancer
Assistance Publique - Hôpitaux de Paris 112
Testing effectiveness (Phase 2)Looking for participantsNCT07749365
What this trial is testing

Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaPCNSL (Primary CNS Lymphoma)
The First Affiliated Hospital of Xiamen University 53
Testing effectiveness (Phase 2)Looking for participantsNCT07346144
What this trial is testing

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

Who this might be right for
Glioblastoma (GBM)High Grade GliomasRecurrent Glioblastoma+1 more
Trogenix ltd 68
Not applicableStudy completedNCT00745381
What this trial is testing

A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors

Who this might be right for
Gastric CancerPancreatic Cancer
Memorial Sloan Kettering Cancer Center 238
Early research (Phase 1)Looking for participantsNCT07143812
What this trial is testing

Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma (GBM)Newly Diagnosed Glioblastoma Multiforme
CHA University 10
Testing effectiveness (Phase 2)Study completedNCT02191930
What this trial is testing

Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Cologne 70
Not applicableStudy completedNCT02919865
What this trial is testing

MR Perfusion Methods in Patients With Suspected Recurrent High Grade Gliomas

Who this might be right for
Glioma
Ottawa Hospital Research Institute 50
Next Page